The Chinese-made COVID-19 inactivated vaccines may be available on the market by the end of 2020, according to China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation on the 2020 Zhongguancun Forum held here.
In addition, the government of India has formed a National Expert Group on Vaccine Administration for COVID-19, which is creating a strategy on the procurement mechanisms for vaccine, including both indigenous and worldwide manufacturing, along with guiding principles for prioritisation of population groups for vaccination.
Sanofi and GSK started clinical trials of their vaccine this month and aim to reach the final testing stage by December.
If the advanced clinical trials of Covid-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of state for health Ashwini Choubey informed Lok Sabha on Friday.
Jennifer Aniston, Brad Pitt get flirty during virtual reunion
Jennifer and Brad got married in Malibu, California, in July 2000 and announced their separation fives years later. Henry Golding , Jimmy Kimmel , John Legend and Ray Liotta also took part, along with host Dane Cook .
"The MMA believes even if Malaysia has its own bilateral negotiations for a vaccine, signing up for the Covax Vaccine Plan can be an added option that will guarantee access to vaccines for Covid-19".
After Moderna released a 135-page document on Thursday giving details about ongoing phase-3 trials of its coronavirus candidate vaccine, Pfizer has now come out with similar information, releasing the full roadmap of how the trials are being conducted.
The trial in Russia began September 9, and Russian officials have said they expect early results before the end of the year, though the Gamaleya Institute, the scientific body that developed the vaccine, has scheduled the trial to continue until May. The deal also gives the USA government an option for an additional 500 million doses over the long term.
Dr. Thacker, who is also an executive director of the International Pediatric Association, said there may be ways to fast-track the trials, but transparency was crucial. The participants of the trial are expected to receive another shot of the adenovirus-based viral vector vaccine within 21 days of the first. In late August, phase III trials, involving at least 40,000 people, were launched in Russian Federation.
"Maybe nothing scary is happening in reality and only the announcement was scary", he said. "Phase II clinical trials are ongoing", Choubey stated at the Lok Sabha.